← 產業報告目錄
Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Application (Oncology, Neurology, Infectious Disease, Respiratory, Dermatology) And Formulation (Injectable, Topical, Inhaled, Oral), Region And Segment Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-03-26頁數 180報告編號 INSIGHTACE-af61e425c0
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
Industry analysis indicates the Formulation Development Outsourcing Market globally will advance at a 7.80% CAGR during 2024–2031.
Formulation Development Outsourcing covers reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, driven by demographic shifts and policy support.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Formulation Development Outsourcing Market Snapshot
Chapter 4. Global Formulation Development Outsourcing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Service Estimates & Trend Analysis
5.1. by Service & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Service:
5.2.1. Percutaneous Endovascular Aneurysm Repair (EVAR)
5.2.2. Fenestrated EVAR
5.2.3. Aortic Stents Biodegradable Stents
5.2.4. Self- Expanding Nitinol Stents
5.2.5. Thoracic Aortic Aneurysm Grafts
5.2.6. Other Devices
Chapter 6. Market Segmentation 2: by Formulation Estimates & Trend Analysis
6.1. by Formulation & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Formulation:
6.2.1. Ballon Angioplasty
6.2.2. Angioplasty With Stent Replacement
6.2.3. Drug-Eluting Stents Renal Artery Angioplasty and Stenting Carotid Artery
6.2.4. Thrombosis
6.2.5. Renal Artery Angioplasty and Stenting
6.2.6. Transfemoral Carotid Artery Revascularization
6.2.7. Intravascular Brachytherapy
6.2.8. Carotid Artery Stenting
Chapter 7. Market Segmentation 3: by Therapeutic Area Estimates & Trend Analysis
7.1. by Therapeutic Area & Market Share, 2023 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Area:
7.2.1. Pulmonary
7.2.2. Vascular
7.2.3. Cardiology Surgery
7.2.4. Neurology
7.2.5. Radiology
Chapter 8. Formulation Development Outsourcing Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2023-2031
8.1.2. North America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
8.1.3. North America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
8.1.4. North America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.2. Europe
8.2.1. Europe Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2023-2031
8.2.2. Europe Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
8.2.3. Europe Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
8.2.4. Europe Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2023-2031
8.3.2. Asia Pacific Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
8.3.3. Asia-Pacific Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
8.3.4. Asia Pacific Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.4. Latin America
8.4.1. Latin America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2023-2031
8.4.2. Latin America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
8.4.3. Latin America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
8.4.4. Latin America Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2023-2031
8.5.2. Middle East & Africa Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Formulation, 2023-2031
8.5.3. Middle East & Africa Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Area, 2023-2031
8.5.4. Middle East & Africa Formulation Development Outsourcing Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. SGS S.A.
9.2.2. Intertek Group plc
9.2.3. Recipharm
9.2.4. Lonza
9.2.5. Charles River Laboratories International, Inc.
9.2.6. Eurofins Scientific SE
9.2.7. Element
9.2.8. Labcorp
9.2.9. Thermo Fisher Scientific, Inc. (Patheon)
9.2.10. Catalent Inc.
9.2.11. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們